Results 1 to 10 of about 40,760 (162)

Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency. [PDF]

J Hum Immun
Gilbert KM, Aglan M, Jogdand A, Khairnar NV, Ssemaganda H, Ong MS, Farmer JR.   +6 more
europepmc   +1 more source

Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study. [PDF]

Nat Commun
Chong KC, Wei Y, Wong CKH, Xiong X, Wang H, Hung CT, Li C, Yam CHK, Chow TY, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Zhao S, Yeoh EK, Lin G.   +16 more
europepmc   +1 more source

Persistent SARS-CoV-2 Infection in an Immunocompromised Host Treated Successfully With the Japanese Herbal Medicine, Mao-to: A Case Report. [PDF]

Am J Case Rep
Yamada T, Sonoda S, Otsuka M, Shirai T, Tateishi T, Furusawa H, Miyazaki Y.   +6 more
europepmc   +1 more source

HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative. [PDF]

Open Forum Infect Dis
Essam Nkodo EN, Maheria P, Hurwitz E, Anzalone AJ, Li D, Islam JY, Sun J, Varley CD, Butzin-Dozier Z, Safo SE, Kirksey K, Hassan SA, Camacho-Rivera M, Patel RC, Fadul N.   +14 more
europepmc   +1 more source

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV. [PDF]

Antimicrob Agents Chemother
Tsirizani L, Waalewijn H, Szubert A, Mulenga V, Chabala C, Bwakura-Dangarembizi M, Chitsamatanga M, Rutebarika DA, Musiime V, Kasozi M, Lugemwa A, McIlleron HM, Burger DM, Gibb DM, Colbers A, Denti P, Wasmann RE, CHAPAS-4 trial team.   +17 more
europepmc   +1 more source

Successful Treatment of Multiple Myeloma Complicated With SARS-CoV-2 Infection: A Case Report. [PDF]

Case Rep Med
Meng Y, Duan B, Gao L, Huang W, Wan F.
europepmc   +1 more source

Prevalence and correlates of hyperbilirubinemia among people living with HIV (PLHIV) receiving atazanavir boosted with ritonavir (ATV/r). [PDF]

BMC Gastroenterol
Farrokhi H, Shahmohamadi E, Pashaei A, Emadi Koochak H, Nooralioghli Parikhani S, Fathi Amrollah M, Mirzapour P, Dehghan Manshadi SA, SeyedAlinaghi S, Hackett D.   +9 more
europepmc   +1 more source

Drug-related problems and challenges encountered by pharmacists in nirmatrelvir/ritonavir counselling during the covid-19 pandemic: a multi-center study. [PDF]

Sci Rep
Balan S, Mohan K, Liang VHW, Ghazali HH, Suan CL, Chee CC, En KW, Makhdzir LF, Samsuri NS, Tamyes NMM, Lim JN, Azami NAMN, Samad S, Singh KKC, Khan NN, Chamati SH, Hassan N, Ping KH, Nordin F, Hoong LW, Bakar AAA.   +20 more
europepmc   +1 more source

Persistent Seronegativity and Absence of Intact Proviruses Despite Prolonged Initial Viremia in Early-Treated Perinatal HIV Infection. [PDF]

Open Forum Infect Dis
Charre C, Buseyne F, Mélard A, Gardiennet E, Mariaggi AA, Montange T, Le Chenadec J, Warszawski J, Blanche S, Avettand-Fenoël V, Frange P.   +10 more
europepmc   +1 more source